Kinetics of analgesic response in man; an example with two non-steroidal anti-inflammatory analgesic drugs. 1978

G Sacchetti, and G C Ferrati, and L Parrinello, and A Salami

A double-blind, controlled trial is described in which a total of forty hospital in-patients suffering from severe post-operative pain were randomly allocated to treatment with one of two non-steroidal anti-inflammatory drugs, namely, either indoprofen which has a short half-life (two-hours) or naproxen which has a long half-life (thirteen hours). The drugs were administered orally on a single-dose basis. The doses used in this way were 300 mg of indoprofen or 250 mg of naproxen. Patients scored the severity of their pain on a five-point scale and these scores were recorded prior to and at fixed time intervals up to eight hours following administration of medication. No significant differences emerged between the two test drugs and the duration of the response was also found to be similar for the two compounds despite their very different plasma half-life values.

UI MeSH Term Description Entries
D007216 Indoprofen A drug that has analgesic and anti-inflammatory properties. Following reports of adverse reactions including reports of carcinogenicity in animal studies it was withdrawn from the market worldwide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p21) Dexindoprofen
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009288 Naproxen An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. Aleve,Anaprox,Methoxypropiocin,Naprosin,Naprosyn,Naproxen Sodium,Proxen,Sodium Naproxenate,Synflex,Naproxenate, Sodium,Sodium, Naproxen
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D010666 Phenylpropionates Derivatives of 3-phenylpropionic acid, including its salts and esters.
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

G Sacchetti, and G C Ferrati, and L Parrinello, and A Salami
November 2018, Prostaglandins & other lipid mediators,
G Sacchetti, and G C Ferrati, and L Parrinello, and A Salami
May 1987, Nihon rinsho. Japanese journal of clinical medicine,
G Sacchetti, and G C Ferrati, and L Parrinello, and A Salami
July 1995, Schmerz (Berlin, Germany),
G Sacchetti, and G C Ferrati, and L Parrinello, and A Salami
January 1985, Agents and actions. Supplements,
G Sacchetti, and G C Ferrati, and L Parrinello, and A Salami
January 1988, Agents and actions. Supplements,
G Sacchetti, and G C Ferrati, and L Parrinello, and A Salami
May 1987, Nihon rinsho. Japanese journal of clinical medicine,
G Sacchetti, and G C Ferrati, and L Parrinello, and A Salami
June 1996, Intensive & critical care nursing,
G Sacchetti, and G C Ferrati, and L Parrinello, and A Salami
May 1987, Nihon rinsho. Japanese journal of clinical medicine,
G Sacchetti, and G C Ferrati, and L Parrinello, and A Salami
June 1987, British journal of clinical pharmacology,
G Sacchetti, and G C Ferrati, and L Parrinello, and A Salami
September 1986, Life sciences,
Copied contents to your clipboard!